N-(2-(Cyclohexylamino)-2-oxo-1-(p-tolyl)ethyl)-N-(6-(hydroxyamino)-6-oxohexyl)benzamide

ID: ALA4082736

Chembl Id: CHEMBL4082736

PubChem CID: 137647213

Max Phase: Preclinical

Molecular Formula: C28H37N3O4

Molecular Weight: 479.62

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(C(C(=O)NC2CCCCC2)N(CCCCCC(=O)NO)C(=O)c2ccccc2)cc1

Standard InChI:  InChI=1S/C28H37N3O4/c1-21-16-18-22(19-17-21)26(27(33)29-24-13-7-3-8-14-24)31(20-10-4-9-15-25(32)30-35)28(34)23-11-5-2-6-12-23/h2,5-6,11-12,16-19,24,26,35H,3-4,7-10,13-15,20H2,1H3,(H,29,33)(H,30,32)

Standard InChI Key:  XEGNPGCNJFWYGJ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4082736

    ---

Associated Targets(Human)

HDAC1 Tclin Histone deacetylase 1/2/3/6 (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780cisR (133 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAL-27 (814 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 479.62Molecular Weight (Monoisotopic): 479.2784AlogP: 4.69#Rotatable Bonds: 11
Polar Surface Area: 98.74Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.91CX Basic pKa: CX LogP: 4.50CX LogD: 4.48
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.25Np Likeness Score: -1.09

References

1. Krieger V, Hamacher A, Gertzen CGW, Senger J, Zwinderman MRH, Marek M, Romier C, Dekker FJ, Kurz T, Jung M, Gohlke H, Kassack MU, Hansen FK..  (2017)  Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups.,  60  (13): [PMID:28574690] [10.1021/acs.jmedchem.7b00197]

Source